NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
Clinical Trials
18 trialsNCT03879122 2022-10-26
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Spanish Oncology Genito-Urinary Group
Phase 2/3 Unknown
NCT03061643 2022-03-08
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma
Samsung Medical Center
Phase 2 Unknown
NCT03119857 2021-08-18
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
Göteborg University
Phase 3 Unknown
NCT03432780 2021-01-22
QRT-SOGUG
Spanish Oncology Genito-Urinary Group
Phase 2 Unknown
NCT01803503 2016-06-22
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
National University Hospital, Singapore
Phase 2 Unknown
NCT00452556 2014-03-19
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
Nova Scotia Cancer Centre
Phase 2 Unknown
NCT00002775 2014-01-06
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003633 2013-12-19
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00005960 2013-12-04
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00376792 2013-08-26
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00796458 2013-08-12
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01530295 2012-02-09
Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer
Asan Medical Center
Phase NA Unknown
NCT00870714 2009-03-27
IST 16167
Kansas City Veteran Affairs Medical Center
Phase NA Unknown
NCT00043576 2009-03-12
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Novacea
Phase 2/3 Unknown
NCT00448734 2009-01-21
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Poniard Pharmaceuticals
Phase 1/2 Unknown
NCT00121095 2007-12-21
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Cytogen Corporation
Phase 1/2 Unknown
NCT00215345 2005-09-22
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown